表紙
市場調查報告書

呼吸疾病用吸入器的全球市場:2020年∼2030年

The Global Respiratory Inhalers Market 2020-2030: Dry Powder Inhalers, Single-dose DPI, Multi-dose DPI, Metered Dose Inhalers, Nebulizers, Jet Nebulizers, Ultrasonic Nebulizers, Vibrating-mesh Nebulizers, Asthma, COPD, Others

出版商 Visiongain Ltd 商品編碼 931013
出版日期 內容資訊 英文 168 Pages
商品交期: 最快1-2個工作天內
價格
呼吸疾病用吸入器的全球市場:2020年∼2030年 The Global Respiratory Inhalers Market 2020-2030: Dry Powder Inhalers, Single-dose DPI, Multi-dose DPI, Metered Dose Inhalers, Nebulizers, Jet Nebulizers, Ultrasonic Nebulizers, Vibrating-mesh Nebulizers, Asthma, COPD, Others
出版日期: 2020年01月28日內容資訊: 英文 168 Pages
簡介

全球呼吸疾病用吸入器市場,2019年達到326億美元,在預測期間內的前半部分預計以3.9%的年複合成長率成長。2019年,乾粉吸入劑 (DPI) 次市場,佔全球呼吸疾病用吸入器市場56%。

本報告提供全球呼吸疾病用吸入器市場相關調查分析,市場概要,市場動態,市場預測,主要企業等相關的系統性資訊。

目錄

第1章 報告概要

第2章 呼吸疾病和治療的簡介

  • 呼吸疾病簡介
    • 呼吸疾病分類
    • 氣喘
    • 慢性阻塞性肺病 (COPD)
  • 氣喘、COPD的治療中的主要藥物分類
    • 支氣管擴張劑
    • 臨床實驗的階段
    • 醫療設備的法規

第3章 呼吸疾病用吸入器:全球市場的預測

  • 全球呼吸疾病用吸入器市場
  • 主要的呼吸疾病用吸入產品
  • 呼吸疾病用吸入器市場主要企業
  • 呼吸疾病用吸入器:趨勢與發展

第4章 呼吸疾病用吸入器市場:各產品類型 - 預測

  • 定量吸入器:市場預測
  • 乾粉吸入劑 (DPI) :市場預測
    • 單劑量型DPI
    • 多劑量型DPI
  • 噴霧器:市場預測
    • 噴氣式飛機/壓縮機式噴霧器
    • 超音波噴霧器
    • 震動型網膜噴霧器

第5章 呼吸疾病用吸入器市場:各適應症

  • 氣喘:市場預測
  • COPD:市場預測
  • 其他呼吸疾病:市場預測

第6章 主要國家市場:預測

  • 全球呼吸疾病用吸入器市場各地區明細
  • 全球呼吸疾病用吸入器市場預測
  • 美國的呼吸疾病用吸入器市場
  • 呼吸疾病用吸入器市場EU5個國家
  • 日本呼吸疾病用吸入器市場
  • 金磚四國呼吸疾病用吸入器市場
  • 墨西哥呼吸疾病用吸入器市場預測
  • 加拿大呼吸疾病用吸入器市場預測

第7章 呼吸疾病用吸入器市場主要企業

  • GlaxoSmithKline(GSK)
  • AstraZeneca
  • Boehringer Ingelheim
  • Merck & Co.(Merck)
  • Teva
  • Novartis International AG
  • Chiesi Farmaceutici S.p.A.

第8章 調查採訪

第9章 呼吸疾病用吸入器市場定性分析

  • 市場動態
  • 波特的五力分析

第10章 結論

附錄

目錄
Product Code: PHA0669

Visiongain estimates that the global respiratory inhalers market reached $32.6bn in 2019 and will grow at a CAGR of 3.9% in the first half of the forecast period. In 2019, the Dry Powder Inhalers submarket held 56% of the global respiratory inhalers market.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 168-page report you will receive 121 charts and 2 interviews - all unavailable elsewhere.

The 168-page report provides clear detailed insight into the respiratory inhalers market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Respiratory Inhalers Market from 2020-2030

Forecast of the Global Respiratory Inhalers market by Type of Product:

  • Metered Dose Inhalers (MDIs)
  • Dry Powder Inhalers (DPIs): Single-dose DPIs, Multi-dose DPIs
  • Nebulizers: Jet Nebulizers, Ultrasonic Nebulizers, Vibrating-mesh Nebulizers

Forecast of the Global Respiratory Inhalers market by Indication:

  • Asthma
  • COPD
  • Other Respiratory Diseases

This report provides individual revenue forecasts to 2030 for these national markets:

  • The US
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Japan
  • China
  • India
  • Russia
  • Brazil
  • Mexico
  • Canada

Our study discusses the selected leading companies that are the major players in the respiratory inhalers market:

  • AstraZeneca
  • Boehringer Ingelheim
  • Chiesi Farmaceutici S.p.A.
  • GlaxoSmithKline (GSK)
  • Merck & Co.
  • Novartis
  • Teva

This report discusses factors that drive and restrain this market. As well as opportunities and challenges faced by this market.

This report discusses the Porter's Five Forces Analysis of the respiratory inhalers market.

Key questions answered by this report:

  • How is the Respiratory Inhalers market evolving?
  • What are the drivers and restraints for the growth of the Respiratory Inhalers market?
  • What are the market shares of each segment of the overall Respiratory Inhalers market in 2020?
  • How will each Respiratory Inhalers submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2030?
  • How will the market shares for each Respiratory Inhalers submarket develop from 2020 to 2030?
  • What will be the main driver for the overall market from 2020 to 2030?
  • How will the market shares of the national markets change by 2030 and which geographical region will lead the market in 2030?
  • Who are the leading players and what are their prospects over the forecast period?
  • How will the industry evolve during the period between 2020 and 2030?

Visiongain's study is intended for anyone requiring commercial analyses for the respiratory inhalers market. You find data, trends and predictions.

Buy our report today The Global Respiratory Inhalers Market 2020-2030: Dry Powder Inhalers, Single-dose DPI, Multi-dose DPI, Metered Dose Inhalers, Nebulizers, Jet Nebulizers, Ultrasonic Nebulizers, Vibrating-mesh Nebulizers, Asthma, COPD, Others.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. Global Respiratory Inhalers Market Overview
  • 1.2. Global Respiratory Inhalers Market Segmentation
  • 1.3. Overview of Findings
  • 1.4. Structure of the Report
  • 1.5. Why You Should Read This Report
  • 1.6. How This Report Delivers
  • 1.7. Key Questions Answered by This Analytical Report
  • 1.8. Who is This Report For?
  • 1.9. Methodology
    • 1.9.1. Primary Research
    • 1.9.2. Secondary Research
    • 1.9.3. Market Evaluation & Forecasting Methodology
  • 1.10. Frequently Asked Questions(FAQ)
  • 1.11. Associated Visiongain Reports
  • 1.12. About Visiongain

2. Introduction to Respiratory Disorders and Therapies

  • 2.1. An Introduction to Respiratory Disorders
    • 2.1.1. Classification of Respiratory Disorders
    • 2.1.2. Asthma
    • 2.1.3. Chronic Obstructive Pulmonary Disease(COPD)
  • 2.2. Major Drug Classes in the Treatment of Asthma and COPD
    • 2.2.1. Bronchodilators
    • 2.2.2. Phases of Clinical Trials
    • 2.2.3. Regulation of Medical Devices

3. Respiratory Inhalers: Global Market Forecast 2020-2030

  • 3.1. The Global Respiratory Inhalers Market in 2020
  • 3.2. Leading Respiratory Inhaler Products
  • 3.3. Leading Companies in the Respiratory Inhalers Market
  • 3.4. Respiratory Inhalers: Trends and Developments
    • 3.4.1. FDA Requires Replacement of CFC Inhalers with HFA Inhalers
    • 3.4.2. The WISDOM Trial: Will Steroids Lose Their Role in COPD?
    • 3.4.3. Telehealth: A Promising Market Trend
    • 3.4.4. Lifecycle Management Strategies to Counter Patent Expiry
    • 3.4.5. Advanced Inhaler Technologies to Counter Generic Erosion

4. Respiratory Inhalers Market by Product Type: Forecast 2020-2030

  • 4.1. Metered Dose Inhalers: Market Forecast 2020-2030
  • 4.2. Dry Powder Inhalers: Market Forecast 2020-2030
    • 4.2.1. Single-Dose DPIs: Market Forecast 2020-2030
    • 4.2.2. Multi-Dose DPIs: Market Forecast 2020-2030
  • 4.3. Nebulizers: Market Forecast 2020-2030
    • 4.3.1. Jet/Compressor Nebulizers: Market Forecast 2020-2030
    • 4.3.2. Ultrasonic Nebulizers: Market Forecast 2020-2030
    • 4.3.3. Vibrating-Mesh Nebulizers: Market Forecast 2020-2030

5. Respiratory Inhalers Market by Indication

  • 5.1. Asthma: Market Forecast 2020-2030
  • 5.2. COPD: Market Forecast 2020-2030
  • 5.3. Other Respiratory Diseases: Market Forecast 2020-2030

6. Leading National Markets: Forecast 2020-2030

  • 6.1. Regional Breakdown of the Global Respiratory Inhalers Market
  • 6.2. World Respiratory Inhalers Market Forecast 2018-2030
    • 6.2.1. How will Regional Market Shares Change to 2027?
  • 6.3. The US Respiratory Inhalers Market 2020-2030
    • 6.3.1. The US Respiratory Inhalers Market Forecast 2020-2030
    • 6.3.2. US Respiratory Inhalers Market: Trends and Developments
  • 6.4. EU5 Respiratory Inhalers Market 2020-2030
    • 6.4.1. German Respiratory Inhalers Market Forecast 2020-2030
    • 6.4.2. French Respiratory Inhalers Market Forecast 2020-2030
    • 6.4.3. UK Respiratory Inhalers Market Forecast 2020-2030
    • 6.4.4. Italian Respiratory Inhalers Market Forecast 2020-2030
    • 6.4.5. Spanish Respiratory Inhalers Market Forecast 2020-2030
    • 6.4.6. EU5 Respiratory Inhalers Market: Trends and Developments
  • 6.5. Japanese Respiratory Inhalers Market 2018-2030
  • 6.6. BRIC Respiratory Inhalers Market 2020-2030
    • 6.6.1. Chinese Respiratory Inhalers Market Forecast 2020-2030
    • 6.6.2. Indian Respiratory Inhalers Market Forecast 2020-2030
    • 6.6.3. Brazilian Respiratory Inhalers Market Forecast 2020-2030
    • 6.6.4. Russian Respiratory Inhalers Market Forecast 2020-2030
  • 6.7. Mexican Respiratory Inhalers Market Forecast 2020-2030
  • 6.8. Canadian Respiratory Inhalers Market Forecast 2020-2030

7. Leading Companies in the Respiratory Inhalers Market

  • 7.1. GlaxoSmithKline(GSK)
    • 7.1.1. GSK: Product Portfolio
    • 7.1.2. GSK: Financial Overview
    • 7.1.3. Recent Developments
  • 7.2. AstraZeneca
    • 7.2.1. AstraZeneca: Product Portfolio
    • 7.2.2. AstraZeneca: Financial Overview
    • 7.2.3. Recent Developments
    • 7.2.4. AstraZeneca: Products in Development
  • 7.3. Boehringer Ingelheim
    • 7.3.1. Boehringer Ingelheim: Product Portfolio
    • 7.3.2. Boehringer Ingelheim: Financial Overview
    • 7.3.3. Recent Developments
    • 7.3.4. Boehringer Ingelheim: Respiratory Product Pipeline
  • 7.4. Merck & Co.(Merck)
    • 7.4.1. Merck: Product Portfolio
    • 7.4.2. Merck: Financial Overview
    • 7.4.3. Recent Developments
    • 7.4.4. Merck: Products in Development
  • 7.5. Teva
    • 7.5.1. Teva: Product Portfolio
    • 7.5.2. Teva: Financial Overview
    • 7.5.3. Teva: Recent Developments
    • 7.5.4. Teva: Products in Development
  • 7.6. Novartis International AG
    • 7.6.1. Novartis: Product Portfolio
    • 7.6.2. Novartis: Financial Overview
    • 7.6.3. Novartis: Recent Developments
    • 7.6.4. Novartis: Products Under Development
  • 7.7. Chiesi Farmaceutici S.p.A.
    • 7.7.1. Chiesi: Product Portfolio
    • 7.7.2. Chiesi: Financial Overview
    • 7.7.3. Chiesi: Recent Developments

8. Research Interviews

  • 8.1. Professor Peter J Barnes, Professor of Medicine
    • 8.1.1. Professor Peter J Barnes FRS, FMedSci, Margaret Turner-Warwick Professor of Medicine
    • 8.1.2. Unmet needs of Asthma & COPD Patients
    • 8.1.3. Personalization of Respiratory Disease Treatments
    • 8.1.4. Changing Trends in Prevalence & Incidence
    • 8.1.5. Changes in Class of Inhalers
  • 8.2. David Van Sickle, CEO of Propeller Health
    • 8.2.1. Propeller Health
    • 8.2.2. Unmet needs of Asthma & COPD Patients
    • 8.2.3. Proven Outcomes & Expansion of Propeller Health
    • 8.2.4. Features of Propeller Health Sensors
    • 8.2.5. Major Changes in This Decade

9. Qualitative Analysis of Respiratory Inhalers Market

  • 9.1. Market Dynamics
    • 9.1.1. Drivers and Opportunities
    • 9.1.2. Restraints and Challenges
  • 9.2. Porter's Five Forces Analysis of the Respiratory Inhalers Market
    • 9.2.1. Rivalry among Competitors [Medium]
    • 9.2.2. Threat of New Entrants [Medium]
    • 9.2.3. Power of Suppliers [Medium]
    • 9.2.4. Power of Buyers [High]
    • 9.2.5. Threat of Substitutes [Low]

10. Conclusions

  • 10.1. Respiratory Inhalers: A Maturing Market
  • 10.2. The Global Respiratory Inhalers Market, 2018-2030
  • 10.3. Leading Respiratory Inhalers
  • 10.4. Leading Respiratory Inhaler Companies
  • 10.5. Leading Regional and National Markets
  • 10.6. Global Respiratory Inhalers Market Forecast, 2020-2030
  • 10.7. The Future of Respiratory Inhalers Market

Appendices

  • Glossary
  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • About Visiongain
  • Visiongain report evaluation form

List of Tables:

  • Table 2.1: Classification of Respiratory Diseases
  • Table 2.2: Clinical Trial Phases
  • Table 3.1: - Respiratory Inhalers: Revenue($m) and Market Shares(%), 2018
  • Table 4.1: World Respiratory Inhalers Market Forecast: Revenues($m), AGR(%) and CAGR(%) by Product Type, 2018-2030
  • Table 4.2: World Metered Dose Inhalers Market Forecast: Revenues($m), AGR(%) and CAGR(%), 2018-2030
  • Table 4.3: World Dry Powder Inhalers Market Forecast: Revenues($m), AGR(%) and CAGR(%), by Product Type, 2018-2030
  • Table 4.4: Types of Marketed Breezhaler Devices
  • Table 4.5: Single-dose DPI Market Forecast: Revenues($m), AGR(%) and CAGR(%), 2018-2030
  • Table 4.6: Multi-dose DPI Market Forecast: Revenues($m), AGR(%) and CAGR(%), 2018-2030
  • Table 4.7: World Nebulisers Market Forecast: Revenues($m), AGR(%) and CAGR(%) by Type, 2018-2030
  • Table 4.8: World Jet Nebulisers Market Forecast: Revenues($m), AGR(%) and CAGR(%), 2018-2030
  • Table 4.9: World Ultrasonic Nebulisers Market Forecast: Revenues($m), AGR(%) and CAGR(%), 2018-2030
  • Table 4.10: World Vibrating-Mesh Nebulisers Market Forecast: Revenues($m), AGR(%) and CAGR(%), 2018-2030
  • Table 5.1: World Respiratory Inhalers Market Forecast: Revenues($m), AGR(%) and CAGR(%) by Disease Indication, 2018-2030
  • Table 5.2: World Asthma Market Forecast: Revenues($m), AGR(%) and CAGR(%), 2018-2030
  • Table 5.3: World COPD Market Forecast: Revenues($m), AGR(%) and CAGR(%), 2018- 2030
  • Table 5.4: World Respiratory Inhalers Market for Other Diseases, Forecast: Revenues($m), AGR(%) and CAGR(%), 2018-2030
  • Table 6.1: World Respiratory Inhalers Market: Revenues($m) and Market Shares(%) by Region, 2020
  • Table 6.2: World Respiratory Inhalers Market Forecast: Revenues($m), AGR(%) and CAGR(%) by Region, 2018-2030
  • Table 6.3: Market Shares(%) of Leading Regional Respiratory Inhalers Markets, 2020, 2025 and 2030
  • Table 6.4: US Respiratory Inhalers Market Forecast: Revenues($m), AGR(%) and CAGR(%), 2018-2030
  • Table 6.5: EU5 Respiratory Inhalers Market Forecast: Revenues($m), AGR(%) and CAGR(%) by National Market, 2018-2030
  • Table 6.6: German Respiratory Inhalers Market Forecast: Revenues($m), AGR(%) and CAGR(%), 2018-2030
  • Table 6.7: French Respiratory Inhalers Market Forecast: Revenues($m), AGR(%) and CAGR(%), 2018-2030
  • Table 6.8: UK Respiratory Inhalers Market Forecast: Revenues($m), AGR(%) and CAGR(%), 2018-2030
  • Table 6.9: Italian Respiratory Inhalers Market Forecast: Revenues($m), AGR(%) and CAGR(%), 2018-2030
  • Table 6.10: Spanish Respiratory Inhalers Market Forecast: Revenues($m), AGR(%) and CAGR(%), 2018-2030
  • Table 6.11: Japanese Respiratory Inhalers Market Forecast: Revenues($m), AGR(%) and CAGR(%), 2018-2030
  • Table 6.12: BRIC Respiratory Inhalers Market Forecast: Revenues($m), AGR(%) and CAGR(%), 2018-2030
  • Table 6.13: Chinese Respiratory Inhalers Market Forecast: Revenues($m), AGR(%) and CAGR(%), 2018-2030
  • Table 6.14: Indian Respiratory Inhalers Market Forecast: Revenues($m), AGR(%) and CAGR(%), 2018-2030
  • Table 6.15: Brazilian Respiratory Inhalers Market Forecast: Revenues($m), AGR(%) and CAGR(%), 2018-2030
  • Table 6.16: Russian Respiratory Inhalers Market Forecast: Revenues($m), AGR(%) and CAGR(%), 2018-2030
  • Table 6.17: Mexican Respiratory Inhalers Market Forecast: Revenues($m), AGR(%) and CAGR(%), 2018-2030
  • Table 6.18: Canadian Respiratory Inhalers Market Forecast: Revenues($m), AGR(%) and CAGR(%), 2018-2030
  • Table 7.1: GSK: Overview
  • Table 7.2: GSK: Respiratory Inhaler Products
  • Table 7.3: GSK: Major Respiratory Inhalers Revenue($m), AGR(%), CAGR(%) by Product Type, 2018-2030
  • Table 7.4: GSK: Respiratory Therapies Pipeline
  • Table 7.5: AstraZeneca: Overview
  • Table 7.6: AstraZeneca: Respiratory Inhaler Products
  • Table 7.7: AstraZeneca: Major Respiratory Inhalers Revenue($m), AGR(%) and CAGR(%), by Product Type, 2018-2030
  • Table 7.8: AstraZeneca: Respiratory Therapies Pipeline
  • Table 7.9: Boehringer Ingelheim: Overview
  • Table 7.10: Boehringer Ingelheim: Respiratory Inhaler Products
  • Table 7.11: Boehringer Ingelheim: Major Respiratory Inhalers Revenue($m), AGR(%) and CAGR(%) by Product Type, 2018-2030
  • Table 7.12: Merck: Overview
  • Table 7.13: Merck: Respiratory Inhaler Products
  • Table 7.14: Merck: Respiratory Inhalers Revenue($m), AGR(%), CAGR(%) by Product Type, 2018-2030
  • Table 7.15: Teva: Overview
  • Table 7.16: Teva: Respiratory Inhaler Products
  • Table 7.17: Teva: Respiratory Inhalers Revenue($m), AGR(%), CAGR(%) by Product Type, 2018-2030
  • Table 7.18: Teva: Respiratory Product Pipeline
  • Table 7.19: Novartis: Overview
  • Table 7.20: Novartis: Respiratory Inhaler Products
  • Table 7.21: Novartis: Respiratory Inhalers Revenue($m), AGR(%), CAGR(%) by Product Type, 2018-2030
  • Table 7.22: Novartis: Respiratory Product Pipeline
  • Table 7.23: Chiesi: Overview
  • Table 7.24: Chiesi: Respiratory Inhaler Products
  • Table 7.25: Chiesi: Respiratory Inhalers Revenue($m), AGR(%), CAGR(%) by Product Type, 2018-2030
  • Table 9.1: - Respiratory Inhalers: Revenue($m) and Market Shares(%), 2018

List of Figures

  • Figure 1.1: Ageing Population Estimates 2010-2050
  • Figure 1.2: Global Respiratory Inhalers: Market Segmentation
  • Figure 2.1: Summary of GINA Guidance for Asthma Treatment, 2019
  • Figure 2.2: Summary of GOLD Guidance for COPD Treatment 2019
  • Figure 3.1: World Respiratory Inhalers Market: Market Shares(%) for Major National Markets 2020
  • Figure 3.2: - Respiratory Inhalers: Market Shares(%), 2018
  • Figure 4.1: Respiratory Inhalers Market Forecast: Revenues($m) by Product Type, 2018- 2030
  • Figure 4.2: Metered Dose Inhalers Market Forecast: Revenues($m) and AGR(%), 2018- 2030
  • Figure 4.3: World Dry Powder Inhalers Market Forecast: Revenues($m) by Product Type, 2018-2030
  • Figure 4.4: Single-dose DPI Market Forecast: Revenues($m) and AGR(%), 2020-2030
  • Figure 4.5: Multi-dose DPI Market Forecast: Revenues($m) and AGR(%), 2018-2030
  • Figure 4.6: World Jet Nebulisers Market Forecast: Revenues($m), AGR(%) and CAGR(%), 2018-2030
  • Figure 4.7: World Ultrasonic Nebulisers Market Forecast: Revenues($m), AGR(%) and CAGR(%), 2018-2030
  • Figure 4.8: World Vibrating-Mesh Nebulisers Market Forecast: Revenues($m), AGR(%) and CAGR(%), 2018-2030
  • Figure 5.1: World Respiratory Inhalers Market Forecast: Revenues($m), AGR(%) and CAGR(%) by Disease Indication, 2018-2030
  • Figure 5.2: World Asthma Market Forecast: Revenues($m) and AGR(%), 2018-2030
  • Figure 5.3: World COPD Market Forecast: Revenues($m) and AGR(%), 2018-2030
  • Figure 5.4: World Respiratory Inhalers Market for Other Diseases, Forecast: Revenues($m) and AGR(%), 2018-2030
  • Figure 6.1: Respiratory Inhalers Market: Revenues($m) by Region, 2020
  • Figure 6.2: World Respiratory Inhalers Market: Market Shares(%) by Region, 2020
  • Figure 6.3: World Respiratory Inhalers Market Forecast: Revenues($m) by Region, 2018- 2030
  • Figure 6.4: World Respiratory Inhalers Market: Market Shares(%) by Region, 2020
  • Figure 6.5: World Respiratory Inhalers Market: Market Shares(%) by Region, 2025
  • Figure 6.6: World Respiratory Inhalers Market: Market Shares(%) by Region, 2030
  • Figure 6.7: US Respiratory Inhalers Market Forecast: Revenues($m) and AGR(%), 2018- 2030
  • Figure 6.8: EU5 Respiratory Inhalers Market Forecast: Revenues($m) by National Market, 2018-2030
  • Figure 6.9: German Respiratory Inhalers Market Forecast: Revenues($m) and AGR(%), 2018-2030
  • Figure 6.10: French Respiratory Inhalers Market Forecast: Revenues($m) and AGR(%), 2018-2030
  • Figure 6.11: UK Respiratory Inhalers Market Forecast: Revenues($m), AGR(%), 2018- 2030
  • Figure 6.12: Italian Respiratory Inhalers Market Forecast: Revenues($m) and AGR(%), 2018-2030
  • Figure 6.13: Spanish Respiratory Inhalers Market Forecast: Revenues($m) and AGR(%), 2018-2030
  • Figure 6.14: Japanese Respiratory Inhalers Market Forecast: Revenues($m) and AGR(%), 2018-2030
  • Figure 6.15: BRIC Respiratory Inhalers Market Forecast: Revenues($m) and AGR(%), 2018-2030
  • Figure 6.16: Chinese Respiratory Inhalers Market Forecast: Revenues($m) and AGR(%), 2018-2030
  • Figure 6.17: Indian Respiratory Inhalers Market Forecast: Revenues($m) and AGR(%), 2018-2030
  • Figure 6.18: Brazilian Respiratory Inhalers Market Forecast: Revenues($m) and AGR(%), 2018-2030
  • Figure 6.19: Russian Respiratory Inhalers Market Forecast: Revenues($m) and AGR(%), 2018-2030
  • Figure 6.20: Mexican Respiratory Inhalers Market Forecast: Revenues($m) and AGR(%), 2018-2030
  • Figure 6.21: Canadian Respiratory Inhalers Market Forecast: Revenues($m) and AGR(%), 2018-2030
  • Figure 7.1: GSK: Major Respiratory Inhalers Revenue($m), 2018
  • Figure 7.2: GSK: Major Respiratory Inhalers Revenue Share(%) by Product, 2018
  • Figure 7.3: GSK: Major Respiratory Inhalers Revenue($m) and AGR(%), 2018-2030
  • Figure 7.4: AstraZeneca: Major Respiratory Inhalers Revenue($m), 2018
  • Figure 7.5: AstraZeneca: Major Respiratory Inhalers Revenue Share(%), by Product, 2018
  • Figure 7.6: AstraZeneca: Major Respiratory Inhalers Revenue($m) and AGR(%), 2018-2030
  • Figure 7.7: Boehringer Ingelheim: Major Respiratory Inhalers Revenue($m), 2018
  • Figure 7.8: Boehringer Ingelheim: Major Respiratory Inhalers Revenue Share(%), by Product, 2018
  • Figure 7.9: Boehringer Ingelheim: Major Respiratory Inhalers Revenue($m) and AGR(%), 2018-2030
  • Figure 7.10: Merck: Major Respiratory Inhalers Revenue($m), 2018
  • Figure 7.11: Merck: Major Respiratory Inhalers Revenue Share(%) by Product, 2018
  • Figure 7.12: Merck: Major Respiratory Inhalers Revenue($m) and AGR(%), 2018-2030
  • Figure 7.13: Teva: Major Respiratory Inhalers Revenue($m), 2018
  • Figure 7.14: Teva: Major Respiratory Inhalers Revenue Share(%) by Product, 2018
  • Figure 7.15: Teva: Major Respiratory Inhalers Revenue($m) and AGR(%), 2018-2030
  • Figure 7.16: Novartis: Major Respiratory Inhalers Revenue($m), 2017
  • Figure 7.17: Novartis: Major Respiratory Inhalers Revenue Share(%), by Product, 2018
  • Figure 7.18: Novartis: Major Respiratory Inhalers Revenue($m) and AGR(%), 2018-2030
  • Figure 7.19: Chiesi: Foster Inhaler Revenue($m) and AGR(%), 2018-2030
  • Figure 8.1: Porter's Five Forces Analysis of the Respiratory Inhalers Market, 2018-2030
  • Figure 9.1: Respiratory Inhalers Market Forecast: Revenues($m) by Product Type, 2018-2030

List of Companies Mentioned in the Report:

  • 3M Drug Delivery Systems
  • Actavis
  • Adherium Limited
  • Aerogen
  • Agilent Technology
  • Airssential
  • Allied Healthcare
  • Almirall
  • Astrazeneca
  • Boehringer Ingelheim
  • Briggs Healthcare
  • CareFusion
  • Chiesi
  • Circassia Pharmaceuticals plc
  • Cipla
  • Clement Clarke International
  • Cohero Health
  • DeVilbiss Healthcare
  • Fexicare
  • Gecko Health Innovations
  • GF Health Products
  • GlaxoSmithKline
  • Heyer Medical
  • Hikma
  • IBM Watson Health
  • Innovate Biomed
  • Innoviva
  • Inspiro Medical
  • Mabis Healthcare
  • Medline Surgical
  • Merck
  • MRK Healthcare
  • Mylan
  • Nexus 6
  • Nouvag AG
  • Novartis
  • Omron Healthcare
  • Opko Health
  • Orion Pharma
  • PARI Medical
  • Pfizer
  • Philips Respironics
  • Propeller Health
  • Qualcomm Incorporated
  • Roche
  • Schering-Plough
  • Sunovion Pharma
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceuticals
  • Theravance
  • Vectura
  • Viatris

List of Organizations Mentioned in the Report:

  • Academia Europaea
  • American College of Chest Physicians
  • American Thoracic Society
  • British Lung Foundation
  • Catholic University of Leuven
  • Centers for Disease Control and Prevention
  • Centre for Devices and Radiological Health
  • European Databank on Medical Devices
  • European Medicines Agency
  • European Respiratory Society
  • Food and Drug Administration
  • German Ministry of Health
  • Global Initiative for Asthma
  • Global Initiative for Chronic Obstructive Lung Disease
  • IBM Watson Health
  • Imperial College, London
  • Journal of COPD Foundation
  • Kaohsiung Medical University
  • Margaret Turner Warwick Education Centre
  • Ministry of Health, Labour and Welfare
  • Mount Sinai Hospital
  • MRC Technology
  • National Heart and Lung Institute
  • National Institute for Health Research
  • Royal College of Physicians
  • Royal Society
  • ServicioSanitarioNazionale
  • Tampere University
  • UK NHS
  • the Universities of Athens
  • University of Cambridge
  • University of Ferrara
  • University of Oxford
  • Up-to-Date Pulmonary Diseases
  • US National Heart, Lung, and Blood Institute
  • US National Institutes of Health
  • Weill Cornell Medicine
  • World Health Organization(WHO)